TrialJournal for immunotherapy of cancer2020

Low-dose interferon-alpha preconditioning and adoptive cell therapy in patients with metastatic melanoma refractory to standard (immune) therapies: a phase I/II study.

Els Verdegaal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.